On Monday, Dislog Group and Mediterrania Capital Partners signed a binding term sheet under which Mediterrania Capital Partners (MCP), through its Mediterrania Capital IV fund, will acquire a stake in Dislog Dispositifs Médicaux (DDM) via a reserved capital increase of MAD 400 million.
This fund-raising is intended to support the Group's development and expansion strategy, and to accompany DDM's growth, both organically and through acquisitions.
This partnership is part of Dislog Group's ambition to consolidate its position as a leader in the life sciences industry in Morocco and beyond.
Dislog Dispositifs Médicaux will now consolidate the Group's future acquisitions in the medical devices sector, including Megaflex, Africare, Afrobiomedic and Farmalac.